TG Therapeutics secures $750M credit facility with Blue Owl, boosts buyback to $300M
Source: SeekingAlpha
2026-03-19 07:38:36 ET
More on TG Therapeutics, Blue Owl Capital
- Revisiting Blue Owl: A Superior Business Nestled In A Complex Ecosystem
- Blue Owl: 3 Bear Myths That Don't Hold Up
- Blue Owl Capital: When Growth Becomes A Risk
- Private credit funds face massive redemption wave as wealthy investors head for exits - FT
- Blue Owl fund urges investors to reject Cox and Saba tender offers
Read the full article on Seeking Alpha
For further details see:
TG Therapeutics secures $750M credit facility with Blue Owl, boosts buyback to $300M
TG Therapeutics Inc.
NASDAQ: TGTX
TGTX Trading
-4.35% G/L:
$29.345 Last:
1,647,458 Volume:
$30.60 Open:
TGTX Latest News
March 19, 2026 07:30:00 am
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million
March 16, 2026 04:14:57 pm
This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop
TGTX Stock Data
$4,661,971,279
141,867,445
0.11%
146
N/A
Biotechnology & Life Sciences
Healthcare
US
Morrisville
